TI
APLT

Trexquant Investment’s Applied Therapeutics APLT Stock Holding History

Trexquant Investment’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,091
Closed -$99K – 1326
2021
Q4 		$99K Buy
+11,091
New +$146K 0.01% 1235
2021
Q1 		– Sell
-10,090
Closed -$222K – 1103
2020
Q4 		$222K Buy
+10,090
New +$210K 0.02% 843

Other funds holding APLT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's APLT Position: Q1 2022 in Review

Trexquant Investment sold out of Applied Therapeutics (APLT) in Q1 2022, closing a stake of 11,091 shares — an estimated $99K sold.

Trexquant Investment first reported a position in APLT in Q4 2020 and held it in 2 quarters. The position peaked at $222K in Q4 2020. 71 funds tracked by Wall St. Rank hold APLT as of Q1 2022.

  • Trexquant Investment reported no remaining Applied Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Trexquant Investment sold 11,091 Applied Therapeutics shares in Q1 2022, an estimated $99K.
  • Trexquant Investment first reported a position in Applied Therapeutics in Q4 2020 and held it in 2 quarters.
  • Trexquant Investment's Applied Therapeutics position peaked at $222K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.